Observational Evaluation of Atopic Dermatitis in Pediatric Patients
About the study
Primary Objectives:
To describe the characteristics of pediatric patients with moderate to severe atopic dermatitis (AD) whose disease is not adequately controlled with topical therapies or when those therapies are not medically advisable.
To evaluate the time-course of AD and selected atopic comorbidities.
Secondary Objectives:
To characterize disease burden and unmet need.
To describe real-world treatment patterns (eg, dosing regimens, treatment duration, and reasons for discontinuation and/or switching).
To document the real-world effectiveness and safety of treatments.
Who can take part
You may be eligible to participate in the study if you meet the following criteria:
INCLUSION CRITERIA
Inclusion criteria:
- Patients with moderate to severe AD, according to the Investigator's assessment;
- Currently receiving systemic treatment (including phototherapy) for atopic dermatitis or currently on topical treatment, but otherwise candidates for systemic treatment.
EXCLUSION CRITERIA
Exclusion criteria:
Concurrent participation in an interventional clinical trial which modifies patient care.
The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Study Locations
Enter your ZIP code/Postal code/PIN code to locate study sites near you:
How to Apply
Contact the study center to learn if this study is a good match for you.
Study’s details
Contition
Dermatitis Atopic
Age (in years)
< 11
Participants needed
1228
Est. Completion Date
Mar 14, 2036
Treatment type
Observational [Patient Registry]
Sponsor
Sanofi
ClinicalTrials.gov identifier
NCT03687359
Study number
OBS15333
Understanding Clinical Trials
Get answers to your questions about clinical trials.What is a clinical research?What does taking part in clinical trials involve?What should I ask the trial doctor?